Sestini, P <br/><br/>
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Feb 1996 
 - 572-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/ajrccm.153.2.8564100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adolescent<br/>Adult<br/>Aspirin--adverse effects<br/>Asthma--chemically induced<br/>Bronchial Provocation Tests<br/>Bronchoconstriction--drug effects<br/>Chromatography, High Pressure Liquid<br/>Dinoprostone--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Forced Expiratory Volume<br/>Humans<br/>Leukotriene E4--urine<br/>Lysine--analogs & derivatives<br/>Male<br/>Middle Aged